Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Aztreonam for Inhalation in Non-CF Bronchiectasis
2010-023959-28Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- May 2011
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis and endobronchial infection comparing Aztreonam for Inhalation Solution with Placebo (2 arms). Started May 2011; status: completed.
02
Drugs
aztreonam
03
Conditions
bronchiectasisendobronchial infection
Beyond the preview
Go deeper on 2010-023959-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023959-28.